OrbiMed Capital GP VI LLC's Net Worth

Estimate Recalculated Dec 3, 2025 07:32PM EST

Who is OrbiMed Capital GP VI LLC

OrbiMed Capital GP VI LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include resTORbio, Inc., LogicBio Therapeutics, Inc., 89bio, Inc., SteadyMed Ltd., AVEDRO INC, Turning Point Therapeutics, Inc., CONSTELLATION PHARMACEUTICALS INC, Prelude Therapeutics Inc, Crinetics Pharmaceuticals, Inc., Verona Pharma plc, ALPINE IMMUNE SCIENCES, INC., CTI BIOPHARMA CORP, NeuroPace Inc, Edgewise Therapeutics, Inc., Ikena Oncology, Inc., ARVINAS INC., Prevail Therapeutics Inc., ARS Pharmaceuticals, Inc., Disc Medicine, Inc., GRAYBUG VISION, INC., Oric Pharmaceuticals, Inc., Kala Pharmaceuticals, Inc., scPharmaceuticals Inc., NextCure, Inc., SYNLOGIC, INC., SpringWorks Therapeutics, Inc., and Turnstone Biologics Corp..

SEC CIK

OrbiMed Capital GP VI LLC's CIK is 0001682115

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALPINE IMMUNE SCIENCES, INC.

Investor

Updated May 20, 2024


Form 4	-100.00%	-2.68M	—	—	May 20, 2024	—	Disposition	—	May 18
Form 4	—	—	$12.74	$1.85M	Jan 16, 2024	2.68M	Options	—	Jan 11
Form 4	-13.05%	-1.55M	$19.37	-$28.67M	Dec 29, 2023	10.31M	Sale	—	Dec 27 - Dec 28
Form 4	32.91%	1.01M	$9.40	$9.50M	Sep 21, 2021	4.08M	Purchase	—	Sep 17
Form 4	-16.34%	-600.00K	$14.25	-$8.55M	Dec 30, 2020	3.07M	Sale	—	Dec 28
Form 4	15.69%	517.69K	$5.37	$2.00M	Jan 23, 2019	3.82M	Purchase	—	Jan 18
Form 4	—	3.30M	—	—	Jul 26, 2017	3.30M	Grant	—	Jul 24
Form 3	—	—	—	—	Jul 26, 2017	—	—	—	—


Form 4	-21.01%	-2.00M	$3.50	-$7.00M	Jan 11, 2021	7.52M	Sale	—	Jan 07
Form 3	—	—	—	—	Mar 10, 2020	9.52M	—	—	—
Form 4	66,566.67%	4.99M	—	—	Jun 15, 2017	5.00M	Options	—	Jun 13
Form 3	—	—	—	—	Jun 09, 2017	—	—	—	—


Form 4	0.73%	25.00K	$12.93	$323.25K	Feb 12, 2018	3.45M	Purchase	—	Feb 08
Form 4	1.12%	37.84K	$14.73	$557.38K	Feb 06, 2018	3.42M	Purchase	—	Feb 02
Form 4	11.98%	362.24K	$15.00	$5.43M	Feb 02, 2018	3.39M	Purchase	—	Jan 31 - Feb 01
Form 4	2.47%	72.76K	$14.97	$1.09M	Jan 30, 2018	3.02M	Purchase	—	Jan 26 - Jan 29
Form 4	9.55%	257.29K	$14.88	$3.83M	Jan 24, 2018	2.95M	Purchase	—	Jan 12 - Jan 24
Form 4	9.81%	240.48K	$13.28	$3.19M	Jan 12, 2018	2.69M	Purchase	—	Jan 10 - Jan 12
Form 3	—	—	—	—	Jan 12, 2018	2.45M	—	—	—
Form 4	-77.82%	-8.33M	$15.00	—	Jul 27, 2017	2.38M	Buy-Options	—	Jul 25
Form 3	—	—	—	—	Jul 19, 2017	—	—	—	—


Form 4	8.99%	500.00K	$4.00	$2.00M	Aug 15, 2024	6.06M	Purchase	—	Aug 13
Form 4	16.70%	762.38K	$5.25	$4.00M	Nov 29, 2022	5.56M	Purchase	—	Nov 25
Form 4	40.68%	1.39M	$8.65	$12.00M	May 26, 2020	4.80M	Purchase	—	May 21
Form 4	-81.57%	-15.09M	$14.00	—	Nov 21, 2017	3.41M	Buy-Options	—	Nov 21
Form 3	—	—	—	—	Nov 16, 2017	—	—	—	—


Form 4	-117.68%	-7.91M	$4.16	-$18.51M	Sep 07, 2018	348.50K	Sale	—	Aug 30
Form 4	57.32%	1.76M	$3.02	$7.00M	Apr 27, 2017	4.83M	Purchase	—	Apr 25
Form 3	—	—	—	—	Aug 12, 2016	3.07M	—	—	—


Form 4	82.10%	1.67M	$3.00	$5.00M	Apr 22, 2021	3.70M	Grant	—	Apr 20
Form 4	54.37%	715.00K	$9.75	$6.97M	Jan 30, 2018	2.03M	Grant	—	Jan 26
Form 3	—	—	—	—	Aug 30, 2017	1.31M	—	—	—


Form 4	47.01%	3.13M	$2.40	$7.50M	Jan 26, 2024	11.45M	Purchase	—	Jan 25
Form 4	12.10%	875.00K	$2.09	$1.83M	Jun 29, 2023	8.32M	Purchase	—	Jun 27
Form 4	765.30%	214.28K	$14.00	$3.00M	Dec 14, 2021	7.48M	Grant	—	Dec 10
Form 4	10.25%	524.35K	$13.00	$6.82M	Feb 18, 2021	7.23M	Grant	—	Feb 12
Form 4	—	6.08M	—	—	Sep 17, 2020	6.77M	Grant	—	Sep 15 - Sep 17
Form 4	12.41%	533.34K	$15.00	—	Jan 30, 2018	4.83M	Purchase	—	Jan 30
Form 3	—	—	—	—	Jan 25, 2018	—	—	—	—


Form 4	—	—	—	—	Feb 19, 2019	4.35M	Options	—	Feb 19
Form 3	—	—	—	—	Feb 13, 2019	152.42K	—	—	—


Form 4	-68.42%	-4.39M	$18.00	—	Apr 24, 2019	2.03M	Buy-Options	—	Apr 22
Form 3	—	—	—	—	Apr 16, 2019	—	—	—	—


Form 4	-88.06%	-6.16M	$15.00	—	Jul 24, 2018	835.84K	Buy-Options	—	Jul 23
Form 3	—	—	—	—	Jul 18, 2018	—	—	—	—


Form 4	9.40%	869.57K	$5.75	$5.00M	May 24, 2023	10.65M	Purchase	—	May 22
Form 4	0.75%	41.70K	$60.00	$2.50M	Jan 12, 2021	5.60M	Purchase	—	Jan 11
Form 4/A	128.06%	4.71M	—	—	Sep 30, 2020	8.40M	Purchase	—	Mar 27 - Aug 21
Form 4	8.77%	1.24M	$19.00	$10.00M	Sep 29, 2020	15.33M	Purchase	—	Sep 25 - Sep 29
Form 3	—	—	—	—	Sep 24, 2020	206.91K	—	—	—


Form 4	-11.33%	-482.91K	$20.58	-$9.94M	May 15, 2023	3.78M	Sale	—	May 11 - May 15
Form 4	-15.26%	-6.14M	$22.15	-$136.00M	Dec 27, 2022	34.09M	Sale	—	Dec 22 - Dec 23
Form 3	—	—	—	—	Jan 05, 2021	40.23M	—	—	—


Form 4	-0.85%	-29.21K	$14.02	-$409.43K	May 03, 2024	3.41M	Sale	—	May 01 - May 03
Form 4	-0.05%	-1.78K	$14.06	-$25.04K	Apr 26, 2024	3.44M	Sale	—	Apr 24
Form 4	-1.85%	-64.65K	$14.12	-$913.06K	Apr 23, 2024	3.44M	Sale	—	Apr 19 - Apr 23
Form 4	-0.48%	-16.99K	$14.02	-$238.23K	Apr 18, 2024	3.50M	Sale	—	Apr 16 - Apr 18
Form 4	-12.11%	-485.00K	$14.49	-$7.03M	Apr 15, 2024	3.52M	Sale	—	Apr 11 - Apr 12
Form 4	-0.21%	-8.31K	$9.07	-$75.45K	Oct 04, 2023	4.00M	Sale	—	Oct 02 - Oct 03
Form 4	—	—	—	—	Apr 26, 2021	4.01M	Options	—	Apr 26
Form 4	—	235.00K	$17.00	$4.00M	Apr 23, 2021	235.00K	Purchase	—	Apr 21
Form 3	—	—	—	—	Apr 20, 2021	—	—	—	—


Form 4	3.25%	454.55K	$11.00	$5.00M	Jan 25, 2024	14.76M	Purchase	—	Jan 23
Form 4	3.59%	484.50K	$10.32	$5.00M	Sep 16, 2022	14.30M	Purchase	—	Sep 16
Form 4	1.03%	138.00K	$7.21	$994.98K	May 20, 2022	13.82M	Purchase	—	May 18
Form 4	1.36%	359.38K	$16.00	$5.75M	Mar 31, 2021	26.73M	Purchase	—	Mar 30
Form 3	—	—	—	—	Mar 25, 2021	316.92K	—	—	—


Form 4/A	9.33%	506.31K	—	—	Sep 21, 2023	8.28M	Grant	—	Aug 04
Form 4	24.13%	506.31K	—	—	Sep 14, 2023	8.28M	Grant	—	Aug 04
Form 4	-12.74%	-252.22K	$4.47	-$1.13M	Jun 24, 2022	7.78M	p	—	Jun 22 - Jun 24
Form 4/A	125.29%	10.79M	$8.70	$21.27M	Apr 13, 2021	19.40M	Purchase	—	Dec 21 - Mar 30
Form 4	120.10%	10.79M	$8.70	$21.27M	Apr 01, 2021	19.78M	Purchase	—	Dec 21 - Mar 30
Form 3	—	—	—	—	Mar 25, 2021	—	—	—	—


Form 4	-100.00%	-13.82M	—	—	Jan 26, 2021	—	Disposition	—	Jan 22
Form 4	6.82%	882.35K	$17.00	—	Jun 26, 2019	13.82M	Purchase	—	Jun 24
Form 3	—	—	—	—	Jun 19, 2019	2.43M	—	—	—


Form 4	-100.00%	-83.69K	$13.00	-$1.09M	Aug 28, 2024	8.29M	Sale	—	Aug 26
Form 4	-91.21%	-868.68K	$13.24	-$11.50M	Aug 23, 2024	8.37M	Sale	—	Aug 21 - Aug 23
Form 4	6.65%	500.00K	$6.20	$3.10M	Aug 31, 2023	9.24M	Purchase	—	Aug 29
Form 4	-67.79%	-17.83M	$21.00	$20.00M	Dec 08, 2020	8.74M	Buy-Options	—	Dec 08
Form 3	—	—	—	—	Dec 03, 2020	538.65K	—	—	—


Form 4	4.90%	83.33K	$36.00	$3.00M	Jun 20, 2024	1.79M	Purchase	—	Jun 17
Form 4	-100.00%	-1.72K	$48.62	-$36.62K	Dec 20, 2023	1.70M	Sale	—	Dec 18
Form 4	-20.29%	-433.20K	$56.75	-$24.58M	Dec 15, 2023	1.70M	Sale	—	Dec 14
Form 4	-2.11%	-134.20K	$58.95	-$7.90M	Dec 14, 2023	6.23M	Sale	—	Dec 12 - Dec 14
Form 4	5.03%	108.70K	$23.00	$2.50M	Feb 17, 2023	2.27M	Purchase	—	Feb 15
Form 4	—	2.16M	—	—	Jan 03, 2023	2.16M	Acq/Dis	—	Dec 29
Form 3	—	—	—	—	Jan 03, 2023	1.58M	—	—	—
Form 3	—	—	—	—	Feb 10, 2021	5.83M	—	—	—


Form 4	15.62%	562.50K	$16.00	—	Sep 29, 2020	4.16M	Purchase	—	Sep 25 - Sep 29
Form 3	—	—	—	—	Sep 24, 2020	—	—	—	—


Form 4	22.91%	1.48M	$6.00	$8.89M	Oct 05, 2020	7.95M	Purchase	—	Oct 01
Form 4	-29.23%	-3.61M	$10.00	—	Oct 25, 2018	8.75M	Buy-Options	—	Oct 23
Form 3	—	—	—	—	Oct 18, 2018	—	—	—	—

OrbiMed Capital GP VI LLC's Net Worth

Who is OrbiMed Capital GP VI LLC

SEC CIK

Past Insider Trading and Trends

ALPINE IMMUNE SCIENCES, INC.

CTI BIOPHARMA CORP

Kala Pharmaceuticals, Inc.

scPharmaceuticals Inc.

SteadyMed Ltd.

SYNLOGIC, INC.

Adicet Bio, Inc.

AVEDRO INC

Turning Point Therapeutics, Inc.

CONSTELLATION PHARMACEUTICALS INC

Prelude Therapeutics Inc

Crinetics Pharmaceuticals, Inc.

Verona Pharma plc

NeuroPace Inc

Edgewise Therapeutics, Inc.

Ikena Oncology, Inc.

ARVINAS INC.

Prevail Therapeutics Inc.

ARS Pharmaceuticals, Inc.

Disc Medicine, Inc.

GRAYBUG VISION, INC.

LogicBio Therapeutics, Inc.

89bio, Inc.

Oric Pharmaceuticals, Inc.

NextCure, Inc.

SpringWorks Therapeutics, Inc.

Turnstone Biologics Corp.


Form 4	-1.27%	-70.57K	$8.39	-$592.38K	Jan 27, 2022	5.50M	Sale	—	Jan 25 - Jan 26
Form 4	-6.87%	-275.00K	$28.00	-$7.70M	Sep 23, 2020	3.73M	Sale	—	Sep 21
Form 4	-72.55%	-12.50M	$16.00	$6.70M	Nov 13, 2019	4.73M	Buy-Options	—	Nov 11 - Nov 13
Form 3	—	—	—	—	Nov 08, 2019	611.23K	—	—	—


Form 4	-4.47%	-103.42K	$23.48	-$2.43M	Mar 31, 2021	2.21M	Sale	Scheduled	Mar 29 - Mar 30
Form 4	-4.62%	-112.30K	$24.53	-$2.75M	Mar 26, 2021	2.32M	Sale	Scheduled	Mar 24 - Mar 26
Form 4	-1.34%	-32.94K	$26.21	-$863.34K	Mar 23, 2021	2.43M	Sale	Scheduled	Mar 19 - Mar 23
Form 4	-2.62%	-66.20K	$27.95	-$1.85M	Mar 18, 2021	2.46M	Sale	Scheduled	Mar 16 - Mar 18
Form 4	-8.62%	-238.28K	$30.54	-$7.28M	Mar 15, 2021	2.53M	Sale	Scheduled	Mar 11 - Mar 15
Form 4	11.32%	281.25K	$16.00	—	Apr 28, 2020	2.77M	Purchase	—	Apr 24 - Apr 28
Form 3	—	—	—	—	Apr 23, 2020	—	—	—	—


Form 4	-85.71%	-16.26M	$15.00	—	May 13, 2019	2.71M	Buy-Options	—	May 13
Form 3	—	—	—	—	May 08, 2019	—	—	—	—


Form 4	-2.67%	-153.90K	$31.96	-$4.92M	Sep 14, 2022	5.60M	Sale	—	Sep 12
Form 4	-4.55%	-274.57K	$38.11	-$10.46M	Aug 10, 2022	5.75M	Sale	—	Aug 08 - Aug 09
Form 4	-0.26%	-15.96K	$85.01	-$1.36M	Jul 06, 2021	6.03M	Sale	Scheduled	Jul 01
Form 4	-0.11%	-6.50K	$85.17	-$553.78K	Jun 30, 2021	6.04M	Sale	Scheduled	Jun 28
Form 4	-0.93%	-56.63K	$85.19	-$4.82M	Jun 25, 2021	6.05M	Sale	Scheduled	Jun 23 - Jun 25
Form 4	-0.50%	-30.85K	$85.09	-$2.63M	Jun 14, 2021	6.11M	Sale	Scheduled	Jun 10
Form 4	-0.78%	-48.05K	$85.36	-$4.10M	Jun 09, 2021	6.14M	Sale	Scheduled	Jun 07 - Jun 09
Form 4	-16.47%	-1.22M	$83.19	-$101.49M	Mar 03, 2021	6.19M	Sale	—	Mar 01
Form 4	3.86%	275.00K	$18.00	—	Sep 19, 2019	7.41M	Purchase	—	Sep 17


Form 4	15.53%	416.67K	$12.00	—	Jul 24, 2023	3.10M	Purchase	—	Jul 20
Form 3	—	—	—	—	Jul 20, 2023	—	—	—	—